English
简体中文
Total: £ 56.28
Published Date: 2026-03-05 | Pages: 111 | Tables: 116 | Medical Care
The global Tuberculosis Diagnostics Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Tuberculosis diagnostic testing is the process of detecting Mycobacterium tuberculosis infection and evaluating disease status through a range of methods, such as skin tests, sputum sample analysis, imaging and blood tests, and molecular biology techniques. These tests help to confirm the presence and type of TB.
The North American market for Tuberculosis Diagnostics Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Tuberculosis Diagnostics Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Tuberculosis Diagnostics Testing in Medical Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Tuberculosis Diagnostics Testing include Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Tuberculosis Diagnostics Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tuberculosis Diagnostics Testing. The Tuberculosis Diagnostics Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tuberculosis Diagnostics Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tuberculosis Diagnostics Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company (BD)
BioMerieux SA
Cepheid (Danaher Corporation)
Hologic, Inc.
Hain Lifescience GmbH
Oxford Immunotec (PerkinElmer)
Qiagen N.V.
Roche Molecular Systems Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Segment by Type
Diagnostic Laboratory
Molecular Diagnostics
Cytokine Detection Assay
Others
Segment by Application
Medical Diagnosis
Epidemiologic Investigations
Public Health Control
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Tuberculosis Diagnostics Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Diagnostic Laboratory
1.2.3 Molecular Diagnostics
1.2.4 Cytokine Detection Assay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostics Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Diagnosis
1.3.3 Epidemiologic Investigations
1.3.4 Public Health Control
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostics Testing Market Perspective (2021–2032)
2.2 Global Tuberculosis Diagnostics Testing Growth Trends by Region
2.2.1 Global Tuberculosis Diagnostics Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Tuberculosis Diagnostics Testing Historic Market Size by Region (2021–2026)
2.2.3 Tuberculosis Diagnostics Testing Forecasted Market Size by Region (2027–2032)
2.3 Tuberculosis Diagnostics Testing Market Dynamics
2.3.1 Tuberculosis Diagnostics Testing Industry Trends
2.3.2 Tuberculosis Diagnostics Testing Market Drivers
2.3.3 Tuberculosis Diagnostics Testing Market Challenges
2.3.4 Tuberculosis Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostics Testing Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostics Testing Players by Revenue (2021–2026)
3.1.2 Global Tuberculosis Diagnostics Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Tuberculosis Diagnostics Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Tuberculosis Diagnostics Testing Revenue
3.4 Global Tuberculosis Diagnostics Testing Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics Testing Revenue in 2025
3.5 Global Key Players of Tuberculosis Diagnostics Testing Head Offices and Areas Served
3.6 Global Key Players of Tuberculosis Diagnostics Testing, Products and Applications
3.7 Global Key Players of Tuberculosis Diagnostics Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Tuberculosis Diagnostics Testing Breakdown Data by Type
4.1 Global Tuberculosis Diagnostics Testing Historic Market Size by Type (2021–2026)
4.2 Global Tuberculosis Diagnostics Testing Forecasted Market Size by Type (2027–2032)
5 Tuberculosis Diagnostics Testing Breakdown Data by Application
5.1 Global Tuberculosis Diagnostics Testing Historic Market Size by Application (2021–2026)
5.2 Global Tuberculosis Diagnostics Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Tuberculosis Diagnostics Testing Market Size (2021–2032)
6.2 North America Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)
6.4 North America Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostics Testing Market Size (2021–2032)
7.2 Europe Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)
7.4 Europe Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics Testing Market Size (2021–2032)
8.2 Asia-Pacific Tuberculosis Diagnostics Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Tuberculosis Diagnostics Testing Market Size (2021–2032)
9.2 Latin America Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)
9.4 Latin America Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics Testing Market Size (2021–2032)
10.2 Middle East & Africa Tuberculosis Diagnostics Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tuberculosis Diagnostics Testing Introduction
11.1.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company (BD)
11.2.1 Becton, Dickinson and Company (BD) Company Details
11.2.2 Becton, Dickinson and Company (BD) Business Overview
11.2.3 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Introduction
11.2.4 Becton, Dickinson and Company (BD) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.2.5 Becton, Dickinson and Company (BD) Recent Development
11.3 BioMerieux SA
11.3.1 BioMerieux SA Company Details
11.3.2 BioMerieux SA Business Overview
11.3.3 BioMerieux SA Tuberculosis Diagnostics Testing Introduction
11.3.4 BioMerieux SA Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.3.5 BioMerieux SA Recent Development
11.4 Cepheid (Danaher Corporation)
11.4.1 Cepheid (Danaher Corporation) Company Details
11.4.2 Cepheid (Danaher Corporation) Business Overview
11.4.3 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Introduction
11.4.4 Cepheid (Danaher Corporation) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.4.5 Cepheid (Danaher Corporation) Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Tuberculosis Diagnostics Testing Introduction
11.5.4 Hologic, Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.5.5 Hologic, Inc. Recent Development
11.6 Hain Lifescience GmbH
11.6.1 Hain Lifescience GmbH Company Details
11.6.2 Hain Lifescience GmbH Business Overview
11.6.3 Hain Lifescience GmbH Tuberculosis Diagnostics Testing Introduction
11.6.4 Hain Lifescience GmbH Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.6.5 Hain Lifescience GmbH Recent Development
11.7 Oxford Immunotec (PerkinElmer)
11.7.1 Oxford Immunotec (PerkinElmer) Company Details
11.7.2 Oxford Immunotec (PerkinElmer) Business Overview
11.7.3 Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Introduction
11.7.4 Oxford Immunotec (PerkinElmer) Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.7.5 Oxford Immunotec (PerkinElmer) Recent Development
11.8 Qiagen N.V.
11.8.1 Qiagen N.V. Company Details
11.8.2 Qiagen N.V. Business Overview
11.8.3 Qiagen N.V. Tuberculosis Diagnostics Testing Introduction
11.8.4 Qiagen N.V. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.8.5 Qiagen N.V. Recent Development
11.9 Roche Molecular Systems Inc.
11.9.1 Roche Molecular Systems Inc. Company Details
11.9.2 Roche Molecular Systems Inc. Business Overview
11.9.3 Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Introduction
11.9.4 Roche Molecular Systems Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.9.5 Roche Molecular Systems Inc. Recent Development
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Details
11.10.2 Siemens Healthineers AG Business Overview
11.10.3 Siemens Healthineers AG Tuberculosis Diagnostics Testing Introduction
11.10.4 Siemens Healthineers AG Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.10.5 Siemens Healthineers AG Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Tuberculosis Diagnostics Testing Business (2021–2026)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Diagnostic Laboratory
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Cytokine Detection Assay
Table 5. Key Players of Others
Table 6. Global Tuberculosis Diagnostics Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Tuberculosis Diagnostics Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2021–2026
Table 9. Global Tuberculosis Diagnostics Testing Market Share by Region (2021–2026)
Table 10. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Tuberculosis Diagnostics Testing Market Share by Region (2027–2032)
Table 12. Tuberculosis Diagnostics Testing Market Trends
Table 13. Tuberculosis Diagnostics Testing Market Drivers
Table 14. Tuberculosis Diagnostics Testing Market Challenges
Table 15. Tuberculosis Diagnostics Testing Market Restraints
Table 16. Global Tuberculosis Diagnostics Testing Revenue by Players (US$ Million), 2021–2026
Table 17. Global Tuberculosis Diagnostics Testing Market Share by Players (2021–2026)
Table 18. Global Top Tuberculosis Diagnostics Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tuberculosis Diagnostics Testing Revenue, 2025
Table 19. Ranking of Global Top Tuberculosis Diagnostics Testing Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Tuberculosis Diagnostics Testing Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Tuberculosis Diagnostics Testing, Headquarters and Area Served
Table 22. Global Key Players of Tuberculosis Diagnostics Testing, Products and Applications
Table 23. Global Key Players of Tuberculosis Diagnostics Testing, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Tuberculosis Diagnostics Testing Market Size by Type (US$ Million), 2021–2026
Table 26. Global Tuberculosis Diagnostics Testing Revenue Market Share by Type (2021–2026)
Table 27. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Tuberculosis Diagnostics Testing Revenue Market Share by Type (2027–2032)
Table 29. Global Tuberculosis Diagnostics Testing Market Size by Application (US$ Million), 2021–2026
Table 30. Global Tuberculosis Diagnostics Testing Revenue Market Share by Application (2021–2026)
Table 31. Global Tuberculosis Diagnostics Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Tuberculosis Diagnostics Testing Revenue Market Share by Application (2027–2032)
Table 33. North America Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026
Table 35. North America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Tuberculosis Diagnostics Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Tuberculosis Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Tuberculosis Diagnostics Testing Market Size by Country (US$ Million), 2027–2032
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Tuberculosis Diagnostics Testing Product
Table 51. Abbott Laboratories Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 52. Abbott Laboratories Recent Development
Table 53. Becton, Dickinson and Company (BD) Company Details
Table 54. Becton, Dickinson and Company (BD) Business Overview
Table 55. Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Product
Table 56. Becton, Dickinson and Company (BD) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 57. Becton, Dickinson and Company (BD) Recent Development
Table 58. BioMerieux SA Company Details
Table 59. BioMerieux SA Business Overview
Table 60. BioMerieux SA Tuberculosis Diagnostics Testing Product
Table 61. BioMerieux SA Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 62. BioMerieux SA Recent Development
Table 63. Cepheid (Danaher Corporation) Company Details
Table 64. Cepheid (Danaher Corporation) Business Overview
Table 65. Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Product
Table 66. Cepheid (Danaher Corporation) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 67. Cepheid (Danaher Corporation) Recent Development
Table 68. Hologic, Inc. Company Details
Table 69. Hologic, Inc. Business Overview
Table 70. Hologic, Inc. Tuberculosis Diagnostics Testing Product
Table 71. Hologic, Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 72. Hologic, Inc. Recent Development
Table 73. Hain Lifescience GmbH Company Details
Table 74. Hain Lifescience GmbH Business Overview
Table 75. Hain Lifescience GmbH Tuberculosis Diagnostics Testing Product
Table 76. Hain Lifescience GmbH Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 77. Hain Lifescience GmbH Recent Development
Table 78. Oxford Immunotec (PerkinElmer) Company Details
Table 79. Oxford Immunotec (PerkinElmer) Business Overview
Table 80. Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Product
Table 81. Oxford Immunotec (PerkinElmer) Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 82. Oxford Immunotec (PerkinElmer) Recent Development
Table 83. Qiagen N.V. Company Details
Table 84. Qiagen N.V. Business Overview
Table 85. Qiagen N.V. Tuberculosis Diagnostics Testing Product
Table 86. Qiagen N.V. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 87. Qiagen N.V. Recent Development
Table 88. Roche Molecular Systems Inc. Company Details
Table 89. Roche Molecular Systems Inc. Business Overview
Table 90. Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Product
Table 91. Roche Molecular Systems Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 92. Roche Molecular Systems Inc. Recent Development
Table 93. Siemens Healthineers AG Company Details
Table 94. Siemens Healthineers AG Business Overview
Table 95. Siemens Healthineers AG Tuberculosis Diagnostics Testing Product
Table 96. Siemens Healthineers AG Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 97. Siemens Healthineers AG Recent Development
Table 98. Thermo Fisher Scientific Inc. Company Details
Table 99. Thermo Fisher Scientific Inc. Business Overview
Table 100. Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Product
Table 101. Thermo Fisher Scientific Inc. Revenue in Tuberculosis Diagnostics Testing Business (US$ Million), 2021–2026
Table 102. Thermo Fisher Scientific Inc. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Tuberculosis Diagnostics Testing Picture
Figure 2. Global Tuberculosis Diagnostics Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Tuberculosis Diagnostics Testing Market Share by Type: 2025 vs 2032
Figure 4. Diagnostic Laboratory Features
Figure 5. Molecular Diagnostics Features
Figure 6. Cytokine Detection Assay Features
Figure 7. Others Features
Figure 8. Global Tuberculosis Diagnostics Testing Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Tuberculosis Diagnostics Testing Market Share by Application: 2025 vs 2032
Figure 10. Medical Diagnosis Case Studies
Figure 11. Epidemiologic Investigations Case Studies
Figure 12. Public Health Control Case Studies
Figure 13. Others Case Studies
Figure 14. Tuberculosis Diagnostics Testing Report Years Considered
Figure 15. Global Tuberculosis Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Tuberculosis Diagnostics Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Tuberculosis Diagnostics Testing Market Share by Region: 2025 vs 2032
Figure 18. Global Tuberculosis Diagnostics Testing Market Share by Players in 2025
Figure 19. Global Tuberculosis Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics Testing Revenue in 2025
Figure 21. North America Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)
Figure 23. United States Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)
Figure 27. Germany Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Tuberculosis Diagnostics Testing Market Share by Region (2021–2032)
Figure 35. China Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)
Figure 43. Mexico Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Tuberculosis Diagnostics Testing Market Share by Country (2021–2032)
Figure 47. Israel Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Tuberculosis Diagnostics Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 51. Becton, Dickinson and Company (BD) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 52. BioMerieux SA Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 53. Cepheid (Danaher Corporation) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 54. Hologic, Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 55. Hain Lifescience GmbH Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 56. Oxford Immunotec (PerkinElmer) Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 57. Qiagen N.V. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 58. Roche Molecular Systems Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 59. Siemens Healthineers AG Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tuberculosis Diagnostics Testing Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
